Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, February 1, 2026.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Long-Term Downtrend (-90) - BCRX is in a strong downtrend that is likely to continue. While BCRX is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid BCRX?
MarketClub looks at technical strength and momentum to determine if the timing is right for BCRX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for BCRX
The long-term trend has been DOWN since Aug 1st, 2025 at 8.0200
The intermediate-term trend has been DOWN since Jan 12th, 2026 at 7.2125
The short-term trend has been DOWN since Jan 27th, 2026 at 6.6300
Smart Scan Analysis for BCRX
Based on our trend formula, BCRX is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 6.61 | 6.75 | 6.42 | 6.58 | -0.09 |
| Prev. Close | Volume | Bid | Ask | Time |
| 6.58 | 2391849 | 2026-01-30 15:59:56 |
| Year High | 9.705 | Year High Date | 2018-11-23 |
| Year Low | 4.25 | Year Low Date | 2018-02-05 |
| 52wk High | 11.31 | 52wk High Date | 2025-06-04 |
| 52wk Low | 6 | 52wk Low Date | 2025-10-14 |
| Year End Close | 1.42 | Average Volume | 4,936,764 |
| Shares Outstanding | 210,543 | Short Interest | 3,767,227 |
| % Institutional | 37.1 | Market Cap | 363M |
| Assets | 446,424,000M | Liabilities | 834,313,000M |
| Beta | 1.96 | Volatility | 69.96 |